119 related articles for article (PubMed ID: 37394060)
1. A checklist for a consistent, comprehensive medication review.
Vaffis S; Dhatt H; Anderson E; Le D; Campbell PJ; Nelson M; Black H; Kolobova I; Axon DR; Warholak T
J Am Pharm Assoc (2003); 2023; 63(5):1504-1507.e1. PubMed ID: 37394060
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Comprehensive Medication Review Completion Rates Using 3 Patient Outreach Models.
Miller DE; Roane TE; Salo JA; Hardin HC
J Manag Care Spec Pharm; 2016 Jul; 22(7):796-800. PubMed ID: 27348280
[TBL] [Abstract][Full Text] [Related]
3. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R
J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924
[TBL] [Abstract][Full Text] [Related]
4. Key informant perspectives about telephonic comprehensive medication review services in the United States.
Anderson EJ; Dhatt H; Vaffis S; Nelson ML; Warholak T; Campbell PJ; Black H; Kolobova I; Axon DR
J Am Pharm Assoc (2003); 2022; 62(3):817-825.e1. PubMed ID: 35067476
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Medication Reviews in Long-term Care Facilities: History of Process Implementation and 2015 Results.
O'Shea TE; Zarowitz BJ; Erwin WG
J Manag Care Spec Pharm; 2017 Jan; 23(1):22-26. PubMed ID: 28025922
[TBL] [Abstract][Full Text] [Related]
6. Qualitative analysis of telephonic comprehensive medication review content and delivery.
Dhatt H; Vaffis S; Le D; Axon DR; Campbell PJ; Black H; Kolobova I; Nelson ML; Warholak T
J Am Pharm Assoc (2003); 2023; 63(2):555-565. PubMed ID: 36481091
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive medication review service by embedded pharmacists in primary care: Innovations and impact.
Yoo A; Fennelly JE; Renauer MM; Coe AB; Choe HM; Marshall VD; Parsons D; Farris KB
J Am Pharm Assoc (2003); 2022; 62(2):580-587.e1. PubMed ID: 34696978
[TBL] [Abstract][Full Text] [Related]
8. Positive Medication Changes Resulting from Comprehensive and Noncomprehensive Medication Reviews in a Medicare Part D Population.
Buhl A; Augustine J; Taylor AM; Martin R; Warholak TL
J Manag Care Spec Pharm; 2017 Mar; 23(3):388-394. PubMed ID: 28230451
[TBL] [Abstract][Full Text] [Related]
9. Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit.
Pestka DL; Zillich AJ; Coe AB; Farris KB; Adeoye OA; Snyder ME; Farley JF
J Am Pharm Assoc (2003); 2020; 60(3):456-461. PubMed ID: 31926872
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews.
Doucette WR; Zhang Y; Chrischilles EA; Pendergast JF; Newland BA; Farris KB; Frank J
J Am Pharm Assoc (2003); 2013; 53(5):482-7. PubMed ID: 24030125
[TBL] [Abstract][Full Text] [Related]
11. Evolution of the Comprehensive Medication Review Completion Rate for Medicare Part D Plans: What Do the Stars Tell Us?
Cooke CE; Olshanskaya S; Lee M; Brandt NJ
Sr Care Pharm; 2022 Aug; 37(8):357-365. PubMed ID: 35879850
[No Abstract] [Full Text] [Related]
12. Predictors of Receipt of Comprehensive Medication Reviews in Older Adults.
Coe AB; Farris KB; Solway E; Singer DC; Kirch M; Kullgren JT; Malani PN; Bynum JPW
J Gerontol A Biol Sci Med Sci; 2023 Mar; 78(3):463-469. PubMed ID: 35446953
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of comprehensive medication reviews versus noncomprehensive medication review interventions and subsequent successful medication changes in a Medicare Part D population.
Chinthammit C; Armstrong EP; Boesen K; Martin R; Taylor AM; Warholak T
J Manag Care Spec Pharm; 2015 May; 21(5):381-9. PubMed ID: 25942999
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Plan Type and Comprehensive Medication Reviews on High-Risk Medication Use.
Almodovar AS; Axon DR; Coleman AM; Warholak T; Nahata MC
J Manag Care Spec Pharm; 2018 May; 24(5):416-422. PubMed ID: 29694292
[TBL] [Abstract][Full Text] [Related]
15. A new ballgame: comprehensive medication review.
McSpadden C
Consult Pharm; 2014 Feb; 29(2):76-8, 80-1, 83. PubMed ID: 24513418
[TBL] [Abstract][Full Text] [Related]
16. Consumer decision making for using comprehensive medication review services.
Zhang Y; Doucette WR
J Am Pharm Assoc (2003); 2019; 59(2):168-177.e5. PubMed ID: 30612919
[TBL] [Abstract][Full Text] [Related]
17. Web-Based Electronic Health Record Program: A Twelve-Month Evaluation on Pharmacist's Intervention in Medicare Part D Annual Comprehensive Medication Review.
Chong MT; Chong DS
J Pharm Pract; 2024 Feb; 37(1):132-139. PubMed ID: 36122167
[No Abstract] [Full Text] [Related]
18. Do comprehensive medication review completion rates predict medication use and management quality?
Wang Y; Farley JF; Ferreri SP; Renfro CP
Res Social Adm Pharm; 2019 Apr; 15(4):417-424. PubMed ID: 30917893
[TBL] [Abstract][Full Text] [Related]
19. Stimulating comprehensive medication reviews among Medicare Part D beneficiaries.
Doucette WR; Pendergast JF; Zhang Y; Brown G; Chrischilles EA; Farris KB; Frank J
Am J Manag Care; 2015 Jun; 21(6):e372-8. PubMed ID: 26247578
[TBL] [Abstract][Full Text] [Related]
20. Medicare Part D and quality of prescription medication use in older adults.
Lau DT; Briesacher BA; Touchette DR; Stubbings J; Ng JH
Drugs Aging; 2011 Oct; 28(10):797-807. PubMed ID: 21970307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
